Anika Therapeutics (ANIK) Free Cash Flow (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Free Cash Flow of -$2.1 million for Q2 2026, down 28.8% year-over-year from -$3.0 million in Q2 2025, and up 66.02% quarter-over-quarter from -$6.3 million in Q1 2026.
Anika Therapeutics (ANIK) Free Cash Flow (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Free Cash Flow for 17 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow fell 28.8% year-over-year to -$2.1 million; the TTM figure through Jun 2026 stood at $562000.0 (up 205.05% YoY), while the FY2025 annual figure was $4.4 million, up 287.13% from the prior year.
- Free Cash Flow climbed to -$2.1 million in Q2 2026 per ANIK's latest filing, from -$6.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $5.7 million in Q3 2023 and bottomed at -$9.8 million in Q2 2023.
- Historically, Free Cash Flow has averaged -$926166.7 across 5 years, with a median of -$1.8 million in 2024.
- Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 949.3% — and 2025, when it jumped 1350.55%.
- Anika Therapeutics' Free Cash Flow stood at -$2.0 million in 2022, then soared by 187.79% to $1.8 million in 2023, then sank by 84.71% to $275000.0 in 2024, then surged by 1350.55% to $4.0 million in 2025, then slumped by 153.47% to -$2.1 million in 2026.
- Business Quant data shows ANIK's Free Cash Flow at -$2.1 million in Q2 2026, -$6.3 million in Q1 2026, and $4.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | -2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.13 Mn |
| Jun 30, 2026 | -2.13 Mn |
| Mar 31, 2026 | -6.28 Mn |
| Mar 31, 2026 | -6.28 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | -1.66 Mn |
| Jun 30, 2025 | -1.66 Mn |
| Mar 31, 2025 | -2.95 Mn |
| Mar 31, 2025 | -2.95 Mn |
| Dec 31, 2024 | 275,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 3.80 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | -4.47 Mn |
| Jun 30, 2024 | -4.47 Mn |
| Mar 31, 2024 | -1.93 Mn |
| Mar 31, 2024 | -1.93 Mn |